Home » Topics » Regulatory

Regulatory
RSS

DepoMed reports phase I results for Metformin GR

April 24, 2000

ATP-sensitive K+ channel blockers reportedly useful for vagal nervous system dysfunction

April 24, 2000

CV Therapeutics develops sustained-release formulations of ranolazine

April 24, 2000

Humalog now available in Europe to treat children with diabetes

April 24, 2000

FDA approves first oxazolidinone antimicrobial drug

April 20, 2000

Antihistamines reported useful by Schering-Plough for Rx of sinusitis and otitis media

April 20, 2000

FDA approves Actonel for osteoporosis prevention and treatment

April 20, 2000

Taxol approved in Canada for adjuvant treatment of breast cancer

April 19, 2000

FDA approves Mobic for osteoarthritis symptom relief

April 18, 2000

Celecoxib: use in inflammatory conditions of the head and neck

April 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...